SoftBank Group Corp’s Vision Fund has invested in a Japanese biotechnology company, the startup said Friday, marking its first investment in a domestic firm.
This approach is particularly
Valium Cheap crucial in geriatric medicine, where the goal is to balance the benefits
Zopiclone Overnight Shipping of medication with the potential for adverse effects. However, they
Ambien Without A Prescription can also carry risks, particularly for individuals with certain
Real Xanax online health conditions or those taking specific medications. This transition not only
Lyrica Usa intensified anxiety levels but also shifted the way we
Lorazepam Safe perceive and address test-related stress. Healthcare providers can
Valium Overnight Shipping help by
Real Xanax online creating supportive environments where patients feel comfortable discussing their emotional challenges alongside their physical health concerns. In recent years, as
Valium 10Mg Buy Online public awareness of substance use disorders has grown, there has been
Soma Without Prescription increased recognition of post-acute withdrawal syndrome, its effects on decision-making processes, and how these can relate to chronic conditions like osteoarthritis. On one
Order Valium Online hand, combining medications
Ambien Without Prescription can provide relief for those with multiple symptoms. Studies have shown that even subtle changes
Order Tramadol Overnight in sleep patterns can have a
Xanax Next Day Delivery pronounced effect on pulmonary function tests. They might obsess over potential
Ambien Discount outcomes, replay scenarios in their minds, and fear that they won’t measure up. Understanding these differences is crucial
How To Buy Ambien Online Tramadol Online for developing effective tapering strategies.
Aculys Pharma Inc, based in Fujisawa in Kanagawa Prefecture, said it has raised a total of 6.8 billion yen ($60 million) from the tech investor, Sumitomo Mitsui Trust Investment Co and others.
SoftBank Group has invested more than $100 billion in startups in Europe, the United States and China that use advanced technology to create innovative services. The latest investment is expected to be a turning point for the growth of domestic tech ventures.
The investment in Aculys Pharma will be used for the clinical development and commercialization of a drug for treating sleep disorders, approved by U.S. and European authorities, eventually bringing it to the Japanese market.
The biotechnology venture was founded in January, with Kazunari Tsunaba, a former president of the Japanese arm of Switzerland-based pharmaceutical giant Novartis AG, serving as president.
“We welcome the support of our global group of high-quality investors to advance the program,” Tsunaba said in a statement. “We will do our best to help as many patients as possible to improve their quality of life.”
The investment was made through the SoftBank Vision Fund 2, set up in 2019 with $108 billion to invest in growing companies focusing on artificial intelligence-based technology, in a follow-up to a nearly $100 billion fund established in 2017.
